Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions
Acute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic LeukemiaMyeloid SarcomaExtramedullary Myeloid Tumor
Trial Locations (1)

200080

RECRUITING

Shanghai General Hospital, Shanghai

All Listed Sponsors
lead

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER